Literature DB >> 19442615

COMP-Angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats.

Byung-Hyun Park1, Kyu Yun Jang, Kyu Hyung Kim, Kwang Hun Song, Sang Yong Lee, Sun Jung Yoon, Keun Sang Kwon, Wan-Hee Yoo, Young Jun Koh, Kwon Ha Yoon, Hyun Hwa Son, Gou Young Koh, Jung Ryul Kim.   

Abstract

INTRODUCTION: Ischemic necrosis of the femoral head (INFH) can lead to loss of femoral head architecture and deformity. Moreover, the process of bone healing is intimately associated with angiogenesis. We considered that COMP-Ang1 (an angiogenic factor) might preserve femoral head structure and facilitate bone repair.
METHODS: INFH was induced in the femoral head of rats by dissecting the cervical periosteum and placing a ligature tightly around the femoral neck. Two weeks later, COMP-Ang1 was injected directly into infarcted areas. Rats were divided into the following groups; 1) the sham-operated group (the sham group), 2) the bovine serum albumin-injected group (the BSA group), and 3) the COMP-Ang1-injected group (the COMP-Ang1 group) (n=20/group). At 8 weeks post-surgery animals were sacrificed and radiologic and histomorphometric assessments were performed.
RESULTS: Radiographs obtained at 8 weeks post-surgery showed better preservation of femoral head architecture in the COMP-Ang1 group than in the BSA group. Histological findings and immunostainings of endothelial cells for factor VIII revealed that COMP-Ang1 group animals showed higher levels of vascularity in the secondary ossification center of infarcted femoral heads.
CONCLUSIONS: When INFH was surgically induced in rats, an intraosseous injection of COMP-Ang1 preserved the trabecular framework of the osseous epiphysis and prevented femoral head deformities by promoting angiogenesis and bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442615     DOI: 10.1016/j.bone.2009.01.366

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  8 in total

1.  Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH).

Authors:  Ozgur Basal; Tolga Atay; İbrahim Metin Ciris; Yakup Barbaros Baykal
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

Review 2.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Authors:  A M Isidori; M A Venneri; D Fiore
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256

Review 3.  Bone Microvasculature: Stimulus for Tissue Function and Regeneration.

Authors:  Eun-Jin Lee; Mahim Jain; Stella Alimperti
Journal:  Tissue Eng Part B Rev       Date:  2020-10-22       Impact factor: 7.376

4.  Leptin ameliorates ischemic necrosis of the femoral head in rats with obesity induced by a high-fat diet.

Authors:  Lu Zhou; Kyu Yun Jang; Young Jae Moon; Sajeev Wagle; Kyoung Min Kim; Kwang Bok Lee; Byung-Hyun Park; Jung Ryul Kim
Journal:  Sci Rep       Date:  2015-03-23       Impact factor: 4.379

5.  COMP-angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats.

Authors:  Lu Zhou; Sun Jung Yoon; Kyu Yun Jang; Young Jae Moon; Sajeev Wagle; Kwang Bok Lee; Byung-Hyun Park; Jung Ryul Kim
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

6.  Interferon β protects against avascular osteonecrosis through interleukin 6 inhibition and silent information regulator transcript-1 upregulation.

Authors:  Kyoung Min Kim; Sajeev Wagle; Young Jae Moon; Sung Il Wang; Byung-Hyun Park; Kyu Yun Jang; Jung Ryul Kim
Journal:  Oncotarget       Date:  2017-12-16

7.  Exercise training regulates angiogenic gene expression in white adipose tissue.

Authors:  Hyuek Jong Lee
Journal:  J Exerc Rehabil       Date:  2018-02-26

8.  Metformin coordinates osteoblast/osteoclast differentiation associated with ischemic osteonecrosis.

Authors:  See-Hyoung Park; Mi-Ae Kang; Young Jae Moon; Kyu Yun Jang; Jung Ryul Kim
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.